Stem cell therapy for acute respiratory distress syndrome: A promising future?

Current Opinion in Critical Care

Volumn 22, Issue 1, 2016, Pages 14-20

  Horie, Shahd ^a,b   Masterson, Claire ^b,c   Devaney, James ^a,b   Laffey, John G ^b,c  

^a Anaesthesia   (Canada)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Acute respiratory distress syndrome; Bone marrow mononuclear stem cell; Embryonic stem cells; Endothelial progenitor cells; Mesenchymal stem cell; Mesenchymal stromal cell

Indexed keywords

ALLOGENEIC STEM CELL TRANSPLANTATION; CELL THERAPY; CLINICAL TRIAL (TOPIC); EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; EXPERIMENTAL STUDY; HUMAN; LUNG PARENCHYMA; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MORTALITY RATE; PLURIPOTENT STEM CELL; RESPIRATORY DISTRESS; REVIEW; STEM CELL TRANSPLANTATION; STROMA CELL; ACUTE LUNG INJURY; ADVERSE EFFECTS; ANIMAL; CYTOLOGY; DISEASE MODEL; GRAFT REJECTION; GRAFT SURVIVAL; MORTALITY; PROCEDURES; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ACUTE LUNG INJURY; ANIMALS; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84952717154     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000276     Document Type: Review

References (72)

1. Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012; 122: 2731-2740.
2. Tonelli AR, Zein J, Adams J, Ioannidis JP. Effects of interventions on survival in acute respiratory distress syndrome: an umbrella review of 159 published randomized trials and 29 meta-analyses. Intensive Care Med 2014; 40: 769-787.
3. Mukherjee S, Kong J, Brat DJ. Cancer stem cell division: when the rules of asymmetry are broken. Stem Cells Dev 2015; 24: 405-416.
4. Pardo-Saganta A, Tata PR, Law BM, et al. Parent stem cells can serve as niches for their daughter cells. Nature 2015; 523: 597-601.
5. Kajstura J, Rota M, Hall SR, et al. Evidence for human lung stem cells. N Engl J Med 2011; 364: 1795-1806.
6. Lange AW, Sridharan A, Xu Y, et al. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung. J Mol Cell Biol 2015; 7: 35-47.
7. Yamanaka S. Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 2012; 10: 678-684.
8. Moretti P, Hatlapatka T, Marten D, et al. Mesenchymal stromal cells derived from human umbilical cord tissues: primitive cells with potential for clinical and tissue engineering applications. Adv Biochem Eng Biotechnol 2010; 123: 29-54.
9. Bustos ML, Huleihel L, Meyer EM, et al. Activation of human mesenchymal stem cells impacts their therapeutic abilities in lung injury by increasing interleukin (IL)-10 and IL-1RN levels. Stem Cells Transl Med 2013; 2: 884-895.
10. Keating A. How do mesenchymal stromal cells suppress T cells? Cell Stem Cell 2008; 2: 106-108.
11. Rojas M, Cardenes N, Kocyildirim E, et al. Human adult bone marrow-derived stem cells decrease severity of lipopolysaccharide-induced acute respiratory distress syndrome in sheep. Stem Cell Res Ther 2014; 5: 42.
12. Devaney J, Horie S, Masterson C, et al. Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat. Thorax 2015; 70: 625-635.
13. Asmussen S, Ito H, Traber DL, et al. Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia. Thorax 2014; 69: 819-825.
14. Gotts JE, Abbott J, Matthay MA. Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy. Am J Physiol Lung Cell Mol Physiol 2014; 307: L395-L406.
15. Hayes M, Masterson C, Devaney J, et al. Therapeutic efficacy of human mesenchymal stromal cells in the repair of established ventilator-induced lung injury in the rat. Anesthesiology 2015; 122: 363-373.
16. McAuley DF, Curley GF, Hamid UI, et al. Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation. Am J Physiol Lung Cell Mol Physiol 2014; 306: L809-L815.
17. Wittwer T, Rahmanian P, Choi YH, et al. Mesenchymal stem cell pretreatment of nonheart-beating-donors in experimental lung transplantation. J Cardiothorac Surg 2014; 9: 151.
18. Gore AV, Bible LE, Song K, et al. Mesenchymal stem cells increase Tregulatory cells and improve healing following trauma and hemorrhagic shock. J Trauma Acute Care Surg 2015; 79: 48-52.
19. Krasnodembskaya A, Morrison T, O'Kane C, et al. Human mesenchymal stem cells (MSC) modulate alveolar macrophage polarization in vivo and in vitro. European Respiratory Journal 2014; 44 (Suppl 58).
20. Wakayama H, Hashimoto N, Matsushita Y, et al. Factors secreted from dental pulp stem cells show multifaceted benefits for treating acute lung injury in mice. Cytotherapy 2015; 17: 1119-1129.
21. Goolaerts A, Pellan-Randrianarison N, Larghero J, et al. Conditioned media from mesenchymal stromal cells restore sodium transport and preserve epithelial permeability in an in vitro model of acute alveolar injury. Am J Physiol Lung Cell Mol Physiol 2014; 306: L975-985.
22. Shen Q, Chen B, Xiao Z, et al. Paracrine factors from mesenchymal stem cells attenuate epithelial injury and lung fibrosis. Mol Med Rep 2015; 11: 2831-2837.
23. Fang X, Abbott J, Cheng L, et al. Human mesenchymal stem (stromal) cells promote the resolution of acute lung injury in part through lipoxin A4. J Immunol 2015; 195: 875-881.
24. Monsel A, Zhu YG, Gennai S, et al. Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice. Am J Respir Crit Care Med 2015; 192: 324-336.
25. Zhu YG, Feng XM, Abbott J, et al. Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells 2014; 32: 116-125.
26. Gennai S, Monsel A, Hao Q, et al. Microvesicles derived from human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation. Am J Transplant 2015; 15: 2404-2412.
27. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 2009; 11: 377-391.
28. Sun CK, Leu S, Hsu SY, et al. Mixed serum-deprived and normal adiposederived mesenchymal stem cells against acute lung ischemia-reperfusion injury in rats. Am J Transl Res 2015; 7: 209-231.
29. Jiang X, Qu C, Chang P, et al. Intravenous delivery of adipose-derived mesenchymal stromal cells attenuates acute radiation-induced lung injury in rats. Cytotherapy 2015; 17: 560-570.
30. Mao Y-X, Xu J-F, Seeley EJ, et al. Adipose tissue-derived mesenchymal stem cells attenuate pulmonary infection caused by Pseudomonas aeruginosa via inhibiting overproduction of prostaglandin E2. Stem Cells 2015; 33: 2331-2342.
31. Lu H, Poirier C, Cook T, et al. Conditioned media from adipose stromal cells limit lipopolysaccharide-induced lung injury, endothelial hyperpermeability and apoptosis. J Transl Med 2015; 13: 67.
32. Sung PH, Chang CL, Tsai TH, et al. Apoptotic adipose-derived mesenchymal stem cell therapy protects against lung and kidney injury in sepsis syndrome caused by cecal ligation puncture in rats. Stem Cell Res Ther 2013; 4: 155.
33. Chang YS, Ahn SY, Jeon HB, et al. Critical role of vascular endothelial growth factor secreted by mesenchymal stem cells in hyperoxic lung injury. Am J Respir Cell Mol Biol 2014; 51: 391-399.
34. Min F, Gao F, Li Q, Liu Z. Therapeutic effect of human umbilical cord mesenchymal stem cells modified by angiotensin-converting enzyme 2 gene on bleomycin-induced lung fibrosis injury. Mol Med Rep 2015; 11: 2387-2396.
35. Liu F, Gao F, Li Q, Liu Z. The functional study of human umbilical cord mesenchymal stem cells harbouring angiotensin-converting enzyme 2 in rat acute lung ischemia-reperfusion injury model. Cell Biochem Funct 2014; 32: 580-589.
36. Zhang X, Gao F, Yan Y, et al. Combination therapy with human umbilical cord mesenchymal stem cells and angiotensin-converting enzyme 2 is superior for the treatment of acute lung ischemia-reperfusion injury in rats. Cell Biochem Funct 2015; 33: 113-120.
37. Lee RH, Yu JM, Foskett AM, et al. TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo. Proc Natl Acad Sci 2014; 111: 16766-16771.
38. Bustos ML, Huleihel L, Kapetanaki MG, et al. Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response. Am J Respir Crit Care Med 2014; 189: 787-798.
39. Wilson JG, LiuKD, Zhuo H, et al.Mesenchymal stem(stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med 2015; 3: 24-32.
40. Zheng G, Huang L, Tong H, et al. Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study. Respiratory Research 2014; 15: 39.
41. Yoder MC. Human endothelial progenitor cells. Cold Spring Harb Perspect Med 2012; 2: a006692.
42. Baker CD, Seedorf GJ, Wisniewski BL, et al. Endothelial colony-forming cell conditioned media promote angiogenesis in vitro and prevent pulmonary hypertension in experimental bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2013; 305: L73-81.
43. Burnham EL, Taylor WR, Quyyumi AA, et al. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med 2005; 172: 854-860.
44. Rafat N, Dacho C, Kowanetz G, et al. Bone marrow-derived progenitor cells attenuate inflammation in lipopolysaccharide-induced acute respiratory distress syndrome. BMC Res Notes 2014; 7: 613.
45. Xu X, Narengerile N, Wurina W, et al. Role of endothelial progenitor cell transplantation in rats with sepsis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2015; 27: 514-519.
46. Hu R, Cheng Y, Jing H, Wu H. Erythropoietin promotes the protective properties of transplanted endothelial progenitor cells against acute lung injury via PI3K/Akt pathway. Shock 2014; 42: 327-336.
47. Yin X, Liang Z, Yun Y, Pei L. Intravenous transplantation of BMP2-transduced endothelial progenitor cells attenuates lipopolysaccharide-induced acute lung injury in rats. Cell Physiol Biochem 2015; 35: 2149-2158.
48. Zheng H, Fu G, Dai T, Huang H. Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 2007; 50: 274-280.
49. Fan H, Wong D, Ashton SH, et al. Beneficial effect of a CXCR4 agonist in murine models of systemic inflammation. Inflammation 2012; 35: 130-137.
50. Fan H, Goodwin AJ, Chang E, et al. Endothelial progenitor cells and a stromal cell-derived factor-1alpha analogue synergistically improve survival in sepsis. Am J Respir Crit Care Med 2014; 189: 1509-1519.
51. Li H, Qiang Y, Wang L, et al. Repair of lipopolysaccharide-induced acute lung injury in mice by endothelial progenitor cells, alone and in combination with simvastatin. Chest 2013; 144: 876-886.
52. Llevadot J, Murasawa S, Kureishi Y, et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 2001; 108: 399-405.
53. Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002; 105: 3017-3024.
54. Huang X, Sun K, Zhao YD, et al. Human CD34+ progenitor cells freshly isolated from umbilical cord blood attenuate inflammatory lung injury following LPS challenge. PLoS One 2014; 9: e88814.
55. Nishimura R, Nishiwaki T, Kawasaki T, et al. Hypoxia-induced proliferation of tissue-resident endothelial progenitor cells in the lung. Am J Physiol Lung Cell Mol Physiol 2015; 308: L746-758.
56. Kawasaki T, Nishiwaki T, Sekine A, et al. Vascular repair by tissue-resident endothelial progenitor cells in endotoxin-induced lung injury. Am J Respir Cell Mol Biol 2015; 53: 500-512.
57. Guo W, Li Z, Xie X, et al. Urinary trypsin inhibitor attenuates acute lung injury by improving endothelial progenitor cells functions. Cell Physiol Biochem 2015; 36: 1059-1068.
58. McIntyre BA, Alev C, Mechael R, et al. Expansive generation of functional airway epithelium from human embryonic stem cells. Stem Cells Transl Med 2014; 3: 7-17.
59. Hao Q, Zhu YG, Monsel A, et al. Study of bone marrow and embryonic stem cell-derived human mesenchymal stem cells for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells Transl Med 2015; 4: 832-840.
60. Wang Q, Zhu H, Zhou WG, et al. N-acetylcysteine-pretreated human embryonic mesenchymal stem cell administration protects against bleomycininduced lung injury. Am J Med Sci 2013; 346: 113-122.
61. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
62. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
63. Hawkins F, Kotton DN. Embryonic and induced pluripotent stem cells for lung regeneration. Ann Am Thorac Soc 2015; 12 (Suppl 1): S50-53.
64. Ghaedi M, Niklason LE, Williams J. Development of lung epithelium from induced pluripotent stem cells. Curr Transplant Rep 2015; 2: 81-89.
65. Huang SX, Islam MN, O'Neill J, et al. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat Biotechnol 2014; 32: 84-91.
66. Wong AP, Chin S, Xia S, et al. Efficient generation of functional CFTRexpressing airway epithelial cells from human pluripotent stem cells. Nat Protoc 2015; 10: 363-381.
67. Firth AL, Menon T, Parker GS, et al. Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs. Cell Rep 2015; 12: 1385-1390.
68. Hu P, Pu Y, Li X, et al. Isolation, in vitro culture and identification of a new type of mesenchymal stem cell derived from fetal bovine lung tissues. Mol Med Rep 2015; 12: 3331-3338.
69. Gotoh S, Ito I, Nagasaki T, et al. Generation of alveolar epithelial spheroids via isolated progenitor cells from human pluripotent stem cells. Stem Cell Reports 2014; 3: 394-403.
70. Dye BR, Hill DR, Ferguson MA, et al. In vitro generation of human pluripotent stem cell derived lung organoids. Elife 2015; 4: e05098.
71. Gazdhar A, Grad I, Tamo L, et al. The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor. Stem Cell Res Ther 2014; 5: 123.
72. Lee MO, Moon SH, Jeong HC, et al. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules. Proc Natl Acad Sci U S A 2013; 110: E3281-E3290.